James P. Kelly
2017 - Vanda Pharmaceuticals
In 2017, James P. Kelly earned a total compensation of $2.3M as Executive Vice President, Chief Financial Officer and Treasurer at Vanda Pharmaceuticals, a 5% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $216,225 |
|---|---|
| Option Awards | $832,232 |
| Salary | $465,000 |
| Stock Awards | $754,000 |
| Other | $31,282 |
| Total | $2,298,739 |
Kelly received $832.2K in option awards, accounting for 36% of the total pay in 2017.
Kelly also received $216.2K in non-equity incentive plan, $465K in salary, $754K in stock awards and $31.3K in other compensation.
Rankings
In 2017, James P. Kelly's compensation ranked 4,828th out of 14,666 executives tracked by ExecPay. In other words, Kelly earned more than 67.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,828 out of 14,666 | 67th |
Division Manufacturing | 1,719 out of 5,768 | 70th |
Major group Chemicals And Allied Products | 511 out of 2,074 | 75th |
Industry group Drugs | 395 out of 1,730 | 77th |
Industry Pharmaceutical Preparations | 314 out of 1,329 | 76th |
Source: SEC filing on April 27, 2018.
Kelly's colleagues
We found four more compensation records of executives who worked with James P. Kelly at Vanda Pharmaceuticals in 2017.
2017
Mihael Polymeropoulos
Vanda Pharmaceuticals
Chief Executive Officer
2017
Gian Reverberi
Vanda Pharmaceuticals
Senior Vice President, Chief Commercial Officer
2017
Gunther Birznieks
Vanda Pharmaceuticals
Senior Vice President, Business Development
2017
Richard Gulino
Vanda Pharmaceuticals